KR860001864B1 - 치환이미다졸 유도체의 제조방법 - Google Patents

치환이미다졸 유도체의 제조방법 Download PDF

Info

Publication number
KR860001864B1
KR860001864B1 KR828203024A KR820003024A KR860001864B1 KR 860001864 B1 KR860001864 B1 KR 860001864B1 KR 828203024 A KR828203024 A KR 828203024A KR 820003024 A KR820003024 A KR 820003024A KR 860001864 B1 KR860001864 B1 KR 860001864B1
Authority
KR
South Korea
Prior art keywords
formula
hydrogen
compound
same time
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR828203024A
Other languages
English (en)
Korean (ko)
Other versions
KR840000507A (ko
Inventor
요하네스카르얄라이넨 아르토
오이바 안테로 쿠르켈라 카우코
칼레르보 포얄라 에스코
Original Assignee
카이 페슨스트룀
화아모스 그룹 리미팃드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 카이 페슨스트룀, 화아모스 그룹 리미팃드 filed Critical 카이 페슨스트룀
Publication of KR840000507A publication Critical patent/KR840000507A/ko
Application granted granted Critical
Publication of KR860001864B1 publication Critical patent/KR860001864B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/69—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/213—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C49/217—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR828203024A 1981-07-10 1982-07-07 치환이미다졸 유도체의 제조방법 Expired KR860001864B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8121333 1981-07-10
GB08121333A GB2101114B (en) 1981-07-10 1981-07-10 Substituted imidazole derivatives and their preparation and use

Publications (2)

Publication Number Publication Date
KR840000507A KR840000507A (ko) 1984-02-22
KR860001864B1 true KR860001864B1 (ko) 1986-10-24

Family

ID=10523160

Family Applications (1)

Application Number Title Priority Date Filing Date
KR828203024A Expired KR860001864B1 (ko) 1981-07-10 1982-07-07 치환이미다졸 유도체의 제조방법

Country Status (23)

Country Link
US (3) US4544664A (cg-RX-API-DMAC10.html)
EP (1) EP0072615B1 (cg-RX-API-DMAC10.html)
JP (1) JPS5818365A (cg-RX-API-DMAC10.html)
KR (1) KR860001864B1 (cg-RX-API-DMAC10.html)
AT (1) ATE17121T1 (cg-RX-API-DMAC10.html)
AU (1) AU554125B2 (cg-RX-API-DMAC10.html)
BG (1) BG60763B2 (cg-RX-API-DMAC10.html)
CA (1) CA1184559A (cg-RX-API-DMAC10.html)
DD (1) DD207713A1 (cg-RX-API-DMAC10.html)
DE (1) DE3268111D1 (cg-RX-API-DMAC10.html)
DK (2) DK158307C (cg-RX-API-DMAC10.html)
FI (1) FI77858C (cg-RX-API-DMAC10.html)
GB (1) GB2101114B (cg-RX-API-DMAC10.html)
HK (1) HK8289A (cg-RX-API-DMAC10.html)
HU (1) HU187773B (cg-RX-API-DMAC10.html)
IE (1) IE53244B1 (cg-RX-API-DMAC10.html)
IL (1) IL66271A (cg-RX-API-DMAC10.html)
NO (1) NO160439C (cg-RX-API-DMAC10.html)
NZ (1) NZ201176A (cg-RX-API-DMAC10.html)
SG (1) SG65388G (cg-RX-API-DMAC10.html)
SU (1) SU1241990A3 (cg-RX-API-DMAC10.html)
UA (1) UA5557A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA824875B (cg-RX-API-DMAC10.html)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4482723A (en) * 1983-04-11 1984-11-13 Pfizer Inc. Process for preparation of 4-acetyl-2-substituted-imidazoles
US4661508A (en) * 1984-06-18 1987-04-28 Eli Lilly And Company Aromatase inhibiting α,α-diphenyl-4(5)imidazole-methanes or -ethanes
ZA854400B (en) * 1984-06-18 1987-02-25 Lilly Co Eli 4(5)-substituted imidazoles
US4605661A (en) * 1984-06-18 1986-08-12 Eli Lilly And Company Aromastase inhibiting α,α-diarylimidazole-4(5)-propionitriles, α,α-diarylimidazole-4(5)-propionamides, and 4(5)-(2,2-diarylethyl)imidazoles
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
US4600683A (en) * 1985-04-22 1986-07-15 International Business Machines Corp. Cross-linked polyalkenyl phenol based photoresist compositions
GB8626287D0 (en) * 1986-11-04 1986-12-03 Ucb Sa Substituted 1h-imidazoles
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2210875B (en) * 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
GB8810067D0 (en) 1988-04-28 1988-06-02 Ucb Sa Substituted 1-(1h-imidazol-4-yl)alkyl-benzamides
US5439928A (en) * 1989-03-30 1995-08-08 Orion-Yhtyma Oy Aromatase inhibiting 4(5)-imidazoles
GB2229719B (en) * 1989-03-30 1992-04-29 Farmos Oy Novel aromatase inhibiting 4(5)-imidazoles
US5124157A (en) 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5151526A (en) * 1990-10-11 1992-09-29 The United States Of America As Represented By The Secretary Of The Army 4-[1-(1-naphthalenyl)ethyl]-1H-imidazole, method of making and use as an anesthetic
DE4042492C2 (de) * 1990-10-18 1995-04-13 Heinz W Dr Joseph Verwendung von 4,5-Di-n-hexylimidazol zur Herstellung von fungiziden Mitteln
GB2256135B (en) * 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
GB9111732D0 (en) * 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
SE9302333D0 (sv) * 1993-07-06 1993-07-06 Ab Astra New compounds
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
UA64751C2 (uk) 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
AR015744A1 (es) * 1998-04-01 2001-05-16 Orion Corp Uso de dexmedetomidina para sedacion en terapia intensiva
US6231594B1 (en) 1999-08-11 2001-05-15 Radiant Medical, Inc. Method of controlling body temperature while reducing shivering
US6518257B1 (en) * 1999-10-22 2003-02-11 Takeda Chemical Industries, Ltd. 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof
US6582457B2 (en) * 2001-02-15 2003-06-24 Radiant Medical, Inc. Method of controlling body temperature while reducing shivering
CN100516040C (zh) 2003-03-07 2009-07-22 安斯泰来制药有限公司 具有2,6-二取代苯乙烯基的含氮杂环衍生物
JP2009524616A (ja) * 2006-01-27 2009-07-02 エフ.ホフマン−ラ ロシュ アーゲー Cns疾患のための4−イミダゾール誘導体の使用
EP1918282A1 (en) * 2006-11-06 2008-05-07 "Joint Stock Company Grindeks" Method for preparing medetomidine and its salts
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
US8124774B2 (en) 2007-05-23 2012-02-28 Allergan, Inc. Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds
PL2155733T3 (pl) 2007-05-23 2013-02-28 Allergan Inc Cykliczne laktamy do leczenia jaskry lub podwyższonego ciśnienia śródgałkowego
GB2453982B (en) * 2007-10-24 2009-09-16 Norbrook Lab Ltd Chemical process for the preparation of Medetomidine
US7902247B2 (en) 2008-01-09 2011-03-08 Allergan, Inc. Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors
EP2250153B1 (en) * 2008-01-18 2013-06-19 Allergan, Inc. Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
US8555875B2 (en) 2008-12-23 2013-10-15 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN101921234B (zh) * 2009-06-12 2012-05-30 中国中化股份有限公司 一种制备美托咪啶的方法
CN102753532B (zh) 2009-12-09 2015-05-13 I-技术有限公司 美托咪定的制备方法
CN101805294B (zh) * 2010-01-12 2015-06-10 北京华禧联合科技发展有限公司 盐酸右美托咪定关键中间体的制备
RU2448095C1 (ru) * 2010-12-09 2012-04-20 Олег Геннадьевич Еремин Способ получения детомидина или его нетоксичных фармацевтически приемлемых солей
RU2448094C1 (ru) * 2010-12-09 2012-04-20 Олег Геннадьевич Еремин Улучшенный способ получения медетомидина или его нетоксичных фармацевтически приемлемых солей
IN2014DN00144A (cg-RX-API-DMAC10.html) * 2011-07-22 2015-05-22 Cambrex Karlskoga Ab
WO2013069025A1 (en) 2011-11-11 2013-05-16 Neon Laboratories Ltd. "process for the preparation of dexmedetomidine"
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
IN2014DN07983A (cg-RX-API-DMAC10.html) * 2012-05-08 2015-05-01 Lonza Ag
JP5777840B2 (ja) 2012-05-08 2015-09-09 ロンザ・リミテッド 2−(2,3−ジメチルフェニル)−1−プロパナールを調製するための方法
WO2012172119A2 (en) * 2012-05-08 2012-12-20 Lonza Ltd Method for the preparation of medetomidine
CA2866437C (en) 2012-06-28 2018-01-02 Lonza Ltd. Method for preparation of medetomidine with chloroacetone
HRP20160250T1 (hr) 2012-06-28 2016-04-08 Lonza Ltd Postupak za pripravu 2-(2,3-dimetilfenil)-1-propanala s kloracetonom
RU2646512C2 (ru) 2013-10-07 2018-03-05 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Устройства для трансдермальной доставки дексмедетомидина и способы их применения
TWI709417B (zh) 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
KR101891185B1 (ko) 2013-10-07 2018-08-24 테이코쿠 팔마 유에스에이, 인코포레이티드 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물
CN104447562A (zh) * 2014-03-27 2015-03-25 宁波天衡药业股份有限公司 一种制备盐酸右美托咪定关键中间体的新方法
AU2016257388A1 (en) 2015-05-06 2017-11-23 I-Tech Ab Medetomidine for use in controlling parasitic crustaceans on fish
US9717796B1 (en) 2016-04-20 2017-08-01 Slypharma, Llc Heat sterilizeable, premixed, ready to use dexmedetomidine solution packaged in a flexible plastic container
CN105884691B (zh) * 2016-06-02 2017-08-25 江苏恒瑞医药股份有限公司 一种制备右美托咪定及其中间体的方法
WO2018065288A1 (de) 2016-10-07 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-[2-phenyl-1-(sulfonylmethyl)vinyl]-imidazo[4,5-b]pyridin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel im pflanzenschutz
KR20190060007A (ko) 2016-10-31 2019-05-31 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치를 이용한 통증을 관리하는 방법
TW201837026A (zh) 2017-01-10 2018-10-16 德商拜耳廠股份有限公司 作為除害劑之雜環衍生物(二)
KR102515694B1 (ko) 2017-01-10 2023-03-29 바이엘 악티엔게젤샤프트 해충 방제제로서의 헤테로사이클 유도체
WO2018182499A1 (en) 2017-03-29 2018-10-04 I-Tech Ab Antifouling article
CN108872431B (zh) * 2018-07-09 2021-03-23 成都倍特药业股份有限公司 一种检测4-(1-(2,5-二甲基苯基)乙基)-1h-咪唑或/和其盐酸盐的方法
US11160791B2 (en) 2018-11-01 2021-11-02 Medefil, Inc. Dexmedetomidine injection premix formulation in ready to use (RTU) bags
CN111217756B (zh) * 2019-12-11 2022-03-11 南京亿华药业有限公司 一种盐酸右美托咪定的制备方法
CN113896684A (zh) * 2020-07-06 2022-01-07 复旦大学 一种美托咪定的制备方法
EP4506340A1 (en) 2022-03-22 2025-02-12 Obshestvo s Ogranichennoj Otvetstvennostju "Vikzdorove Zhivotnyh" Method for producing medetomidine and its derivatives
CN114671811A (zh) * 2022-04-14 2022-06-28 南京正科医药股份有限公司 一种右美托咪定拆分副产物的外消旋化回收方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946804A (en) * 1958-12-29 1960-07-26 Abbott Lab (5-methyl-4-imidazolyl)-diphenyl carbinol salts and lower alkyl quaternaries
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use

Also Published As

Publication number Publication date
DK160610B (da) 1991-04-02
DK630486A (da) 1986-12-29
ZA824875B (en) 1983-05-25
FI822140L (fi) 1983-01-11
DK160610C (da) 1991-09-02
AU8562882A (en) 1983-01-13
JPS5818365A (ja) 1983-02-02
US4639464A (en) 1987-01-27
FI822140A0 (fi) 1982-06-15
EP0072615B1 (en) 1985-12-27
DK158307B (da) 1990-04-30
JPH0372621B2 (cg-RX-API-DMAC10.html) 1991-11-19
BG60763B2 (bg) 1996-02-29
IL66271A (en) 1987-02-27
IE53244B1 (en) 1988-09-14
DE3268111D1 (en) 1986-02-06
DK158307C (da) 1990-10-08
NO160439C (no) 1989-04-19
FI77858C (fi) 1989-05-10
CA1184559A (en) 1985-03-26
UA5557A1 (uk) 1994-12-28
IL66271A0 (en) 1982-11-30
SG65388G (en) 1989-06-16
NZ201176A (en) 1985-08-16
HK8289A (en) 1989-02-03
DK630486D0 (da) 1986-12-29
DK304382A (da) 1983-01-11
HU187773B (en) 1986-02-28
SU1241990A3 (ru) 1986-06-30
KR840000507A (ko) 1984-02-22
ATE17121T1 (de) 1986-01-15
NO160439B (no) 1989-01-09
EP0072615A1 (en) 1983-02-23
GB2101114A (en) 1983-01-12
NO822183L (no) 1983-01-11
GB2101114B (en) 1985-05-22
US4826864A (en) 1989-05-02
FI77858B (fi) 1989-01-31
AU554125B2 (en) 1986-08-07
DD207713A1 (de) 1984-03-14
US4544664A (en) 1985-10-01

Similar Documents

Publication Publication Date Title
EP0072615B1 (en) Substituted imidazole derivatives and their preparation and use
CA1304088C (en) Heteroaryl compounds for treatment of inflammation and allergies
EP0058047B1 (en) Substituted imidazole derivatives and their preparation and use
US4568686A (en) Substituted imidazoles and their use
US4012524A (en) [1-Hydroxy-5-indanyloxy (or thio)]-alkanoic acids
JPS5811850B2 (ja) 1− オキソ −2,2− ジチカン −5− インダニロキシ ( マタハチオ # アルカノイツクアシド
KR890001972B1 (ko) 이미다졸 유도체의 제조방법
IE50524B1 (en) Isoquinoline acetic acids and pharmaceutical compositions thereof
US4081476A (en) 1-Aryl-1-lower alkyl-1-buten-3-ols and ester derivatives
CA1314899C (en) Epoxides
CA1301174C (en) Substituted 1h-imidazoles
US4560696A (en) Analgesic, antipyretic or anti-inflammatory imidazole compounds
CA1119613A (en) Process for preparing benzylidene derivatives
JPH1067749A (ja) キサンテン及びアクリジン誘導体、並びにその使用
JPH07119188B2 (ja) カルコン誘導体
EP0184809B1 (en) Imidazolylalkoxyindanic derivatives, a process for preparing them and pharmaceutical composition containing them
US4891433A (en) Process for the preparation of dibenzothiepin derivative
US4035406A (en) 4-alkyl-4-naphthyl-butanes
US4344966A (en) Anti-inflammatory 1-alkyl-1-phenyl-butanes
KR920006783B1 (ko) 항혈액응고성 살서제인 4-하이드록시쿠마린 유도체의 제조방법
PL117473B1 (en) Process for preparing 4-substituted 1,2-diphenyl-3,5-diketopyrazolidinspirazolidinov
DE4014006A1 (de) Imidazol- und triazolhaltige cyclische ketone
JPH0129176B2 (cg-RX-API-DMAC10.html)
IE914332A1 (en) Substituted dibenzoxa-thiocinones, -12-oxides and¹-12,12-dioxides, a process for their preparation and their¹use in medicaments
PL101822B1 (pl) A method of producing substituted pentane

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19820707

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19851203

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19820707

Comment text: Patent Application

PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19860927

PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19870113

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19870219

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19870219

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19890919

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19901015

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19911005

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19921010

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19930830

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 19941020

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 19951024

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 19961017

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 19971016

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 19981009

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 19991008

Start annual number: 14

End annual number: 14

PR1001 Payment of annual fee

Payment date: 20001018

Start annual number: 15

End annual number: 15

PR1001 Payment of annual fee

Payment date: 20011016

Start annual number: 16

End annual number: 16

PC1801 Expiration of term